I.M. Sechenov First Moscow State Medical University

🇷🇺Russia

Country: 🇷🇺Russia

Ownership: Private

Established: 1758-01-01

Employees: 5K

Market Cap: -

Website: http://www.mma.ru

Clinical Trials

microRNAs in the Diagnosis of Atherosclerotic Plaque Instability

Not Applicable

Recruiting

Conditions: Atherosclerosis of Artery

Interventions: Diagnostic Test: blood microRNA
Diagnostic Test: blood level trimethyl N-oxide
Diagnostic Test: plaque and intima microRNA
Diagnostic Test: histological examination of the plaque

First Posted Date: 2023-01-11

Last Posted Date: 2023-01-11

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 60

Registration Number: NCT05680935

Locations: 🇷🇺
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation

Cardiotoxicity Monitoring With Single-lead Electrocardiogram

Not Applicable

Completed

Conditions: Cardiotoxicity

Interventions: Device: Remote 1-minute single-lead electrocardiogram (ECG) monitoring in cancer patients after the first polychemotherapy cycle.

First Posted Date: 2023-01-09

Last Posted Date: 2024-03-08

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 120

Registration Number: NCT05676606

Locations: 🇷🇺
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation

Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors

Completed

Conditions: Tumors of the Central Nervous System
Childhood Cancer Survivors

Interventions: Diagnostic Test: 12-lead ECG, hormone and lipid blood tests, echocardiography (Echo-CG), cardiopulmonary exercise testing (CPET) and pulse wave analysis

First Posted Date: 2022-12-07

Last Posted Date: 2022-12-07

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 60

Registration Number: NCT05641636

Locations: 🇷🇺
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

Phase 1

Recruiting

Conditions: HFpEF - Heart Failure With Preserved Ejection Fraction
Colchicine

Interventions: Drug: Colchicine

First Posted Date: 2022-12-05

Last Posted Date: 2023-05-03

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 40

Registration Number: NCT05637398

Locations: 🇷🇺
A Shchendrygina, Moscow, Russian Federation
🇷🇺
Anastasia Shchendrygina, Moscow, Russian Federation

Toothpastes With Thermal Water for Oral Health

Phase 4

Completed

Conditions: Gingivitis
Dentin Hypersensitivity

Interventions: Drug: BUCCOTHERM® Sensitive Gums Fluoride-Free
Drug: BUCCOTHERM® Sensitive Gums with Fluoride

First Posted Date: 2022-11-21

Last Posted Date: 2023-03-01

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 84

Registration Number: NCT05623761

Locations: 🇷🇺
Institute of Dentistry of Sechenov University, Moscow, Russian Federation

Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications

Conditions: COVID-19
Endothelial Function
Diastolic Dysfunction
Oxygen Consumption
Quality of Life
Exercise Tolerance

Interventions: Diagnostic Test: Portable cardiac monitor "CardioQvark"
Diagnostic Test: Cardiorespiratory stress test
Diagnostic Test: Analysis of exhaled air using the Compact PTR-MS proton mass spectrometer

First Posted Date: 2022-11-08

Last Posted Date: 2024-03-20

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 100

Registration Number: NCT05608603

Locations: 🇷🇺
I.M. Sechenov First Moscow State Medical University (Sechenov University)ogy, Center "Digital biodesign and personalized healthcare"), Moscow, Russian Federation

Prospective Comparison of the Four Biopsy Methods for Prostate Cancer Detection

Not Applicable

Completed

Conditions: Prostate Cancer
Prostate Adenocarcinoma

Interventions: Procedure: consequently performed 4 biopsy methods (TRUS-guided biopsy, cognitive, fusion and transperineal template mapping biopsy)

First Posted Date: 2022-10-21

Last Posted Date: 2022-10-21

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 102

Registration Number: NCT05589558

Locations: 🇷🇺
Institute for Urology and Reproductive Health, Sechenov University., Moscow, Russian Federation

Increasing the Thickness of Soft Tissues in the Esthetic Zone Around Implants

Not Applicable

Recruiting

Conditions: Soft Tissue Atrophy

Interventions: Procedure: Soft tissue augmentation with CM
Procedure: Soft tissue augmentation with CTG

First Posted Date: 2022-09-23

Last Posted Date: 2022-09-23

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 30

Registration Number: NCT05551962

Locations: 🇷🇺
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation

Use of Erbium Laser for Extraction of the Third Molars

Not Applicable

Not yet recruiting

Conditions: Third Molar Extraction
Impacted Third Molar Tooth

Interventions: Procedure: Third molar extraction by cutting and rotary tools
Procedure: Third molar extraction by erbium laser with wavelength 2.94 nm

First Posted Date: 2022-09-14

Last Posted Date: 2022-09-14

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 60

Registration Number: NCT05540015

Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts.

Recruiting

Conditions: Cardiotoxicity

First Posted Date: 2022-08-19

Last Posted Date: 2023-09-28

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 150

Registration Number: NCT05508087

Locations: 🇷🇺
Sechenov University, Moscow, Russian Federation

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy